Suppression of intestinal dysfunction in a Drosophila model of Parkinson’s disease is neuroprotective

被引:0
|
作者
Giorgio Fedele
Samantha H. Y. Loh
Ivana Celardo
Nuno Santos Leal
Susann Lehmann
Ana C. Costa
L. Miguel Martins
机构
[1] University of Cambridge,MRC Toxicology Unit
来源
Nature Aging | 2022年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The innate immune response mounts a defense against foreign invaders and declines with age. An inappropriate induction of this response can cause diseases. Previous studies showed that mitochondria can be repurposed to promote inflammatory signaling. Damaged mitochondria can also trigger inflammation and promote diseases. Mutations in pink1, a gene required for mitochondrial health, cause Parkinson’s disease, and Drosophila melanogaster pink1 mutants accumulate damaged mitochondria. Here, we show that defective mitochondria in pink1 mutants activate Relish targets and demonstrate that inflammatory signaling causes age-dependent intestinal dysfunction in pink1-mutant flies. These effects result in the death of intestinal cells, metabolic reprogramming and neurotoxicity. We found that Relish signaling is activated downstream of a pathway stimulated by cytosolic DNA. Suppression of Relish in the intestinal midgut of pink1-mutant flies restores mitochondrial function and is neuroprotective. We thus conclude that gut–brain communication modulates neurotoxicity in a fly model of Parkinson’s disease through a mechanism involving mitochondrial dysfunction.
引用
收藏
页码:317 / 331
页数:14
相关论文
共 50 条
  • [31] Measuring Constipation in a Drosophila Model of Parkinson's Disease
    Sodders, Maggie J.
    Shen, Ming
    Olsen, Abby L.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2023, (199):
  • [32] Metabolic alterations in a Drosophila model of Parkinson's disease
    Solana-Manrique, C.
    Sanz, F. J.
    Torregrosa, I.
    Paricio, N.
    MOVEMENT DISORDERS, 2021, 36 : S342 - S342
  • [33] Drosophila melanogaster a Versatile Model of Parkinson's Disease
    Naz, Falaq
    Siddique, Yasir Hasan
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (06) : 487 - 530
  • [34] Drosophila: A Model to Study the Pathogenesis of Parkinson's Disease
    Rahul
    Siddique, Yasir Hasan
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2022, 21 (03) : 259 - 277
  • [35] Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila
    Park, Jeehye
    Kim, Yongsung
    Chung, Jongkyeong
    DISEASE MODELS & MECHANISMS, 2009, 2 (7-8) : 336 - 340
  • [36] Curcumin's Neuroprotective Efficacy in Drosophila Model of Idiopathic Parkinson's Disease Is Phase Specific: Implication of its Therapeutic Effectiveness
    Phom, Limamanen
    Achumi, Bovito
    Alone, Debasmita P.
    Muralidhara
    Yenisetti, Sarat Chandra
    REJUVENATION RESEARCH, 2014, 17 (06) : 481 - 489
  • [37] Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation
    Delgado, M
    Ganea, D
    FASEB JOURNAL, 2003, 17 (03): : 944 - +
  • [38] LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson's Disease
    Ciampelli, Cristina
    Galleri, Grazia
    Galioto, Manuela
    Mereu, Paolo
    Pirastru, Monica
    Bernardoni, Roberto
    Albani, Diego
    Crosio, Claudia
    Iaccarino, Ciro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [39] Neuroprotective Treatments in Parkinson's Disease
    Cinar, Elif
    Cakmakli, Gul Yalcin
    Te, Banu Cahide
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (04) : 189 - 197
  • [40] Is DBS neuroprotective in Parkinson's disease?
    Markaki, E.
    Ellul, J.
    Theodoropoulou, A.
    Kyriazopoulou, V.
    Constantoyannis, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 664 - 664